Novel coronavirus Pneumonia (COVID-19)
Conditions
Interventions
The treatment group:Auricular application pressur + Conventional treatmente
Sponsors
The First Affiliated Hospital of Guizhou Chinese Medicine University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Meet the diagnostic criteria for acute insomnia; 2. COVID-19 Diagnosed Patients; 3. 18 years old and above; 4. Insomnia severity index (ISI), >=8 points; 5. Sign the informed consent form and voluntarily participate in this trial.
Exclusion criteria
Exclusion criteria: 1. Diseases that have not been effectively controlled or are extremely serious by Clinician's Judgment, such as persistent pain from various causes, malignant tumor, Cardiovascular disease (High blood pressure, coronary atherosclerotic heart disease, Cerebral infarction, traumatic brain injury, Parkinson's Disease, dementia, epilepsy), neuroendocrine disease (diabetes, Hyperthyroidism, hypothyroidism), neuromuscular disease Gastrointestinal diseases, etc. (gastroesophageal reflux), etc. insomnia disorder; 2. Mentally disorders patients with suicidal tendencies; 3. Participating in other clinical studies; 4. Pregnant or breastfeeding women or planning to become pregnant during treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insomnia Severity Index; | — |
Countries
China
Contacts
Public ContactDong-Xin Tang
The First Affiliated Hospital of Guizhou Chinese Medicine University
Outcome results
None listed